Pa, I. (2018) “DIFFERENCE IN BLOOD FUNCTION TOXICITY BETWEEN STADIUM IIB-IIIB SQUAMOUS CELL CERVICAL CANCER PATIENTS WITH PACLITAXEL CISPLATIN AND PACLITAXEL CARBOPLATIN CHEMOTHERAPY AT SANGLAH HOSPITAL, DENPASAR”., Asian Journal of Pharmaceutical and Clinical Research, 11(1), pp. 224–227. doi: 10.22159/ajpcr.2018.v11i1.22125.